U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C17H20N2O5S
Molecular Weight 364.416
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHENETICILLIN

SMILES

[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)C(C)OC3=CC=CC=C3)C(O)=O

InChI

InChIKey=NONJJLVGHLVQQM-JHXYUMNGSA-N
InChI=1S/C17H20N2O5S/c1-9(24-10-7-5-4-6-8-10)13(20)18-11-14(21)19-12(16(22)23)17(2,3)25-15(11)19/h4-9,11-12,15H,1-3H3,(H,18,20)(H,22,23)/t9?,11-,12+,15-/m1/s1

HIDE SMILES / InChI

Molecular Formula C17H20N2O5S
Molecular Weight 364.416
Charge 0
Count
Stereochemistry EPIMERIC
Additional Stereochemistry No
Defined Stereocenters 3 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including: doi: 10.1136/bmj.2.5197.534

Pheneticillin (phenoxyethylpenicillin) is an oral penicillin used for the treatment of upper respiratory tract infections; lower respiratory tract infections; skin and soft tissue infections. Pheneticillin inhibits the synthesis of the cell wall by inhibiting the penicillin binding proteins (PBPs) function. It is well absorbed from the gastrointestinal tract. It reaches the pleural and peritoneal cavities but doesn’t cross the blood-brain barrier. Diarrhea has sometimes occurred with therapeutic doses in man.

CNS Activity

Sources: doi: 10.1136/bmj.2.5197.534

Originator

Sources: DOI: 10.1136/bmj.2.5197.534

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Broxil

Approved Use

It is indicated for the treatment of infections, caused by susceptible microorganisms. In particular streptococcal infections, such as: upper respiratory tract infections (for example, pharyngitis); lower respiratory tract infections (for example, pneumonia); skin and soft tissue infections (for example, abscesses or impetigo).

Launch Date

1965
Curative
Broxil

Approved Use

It is indicated for the treatment of infections, caused by susceptible microorganisms. In particular streptococcal infections, such as: upper respiratory tract infections (for example, pharyngitis); lower respiratory tract infections (for example, pneumonia); skin and soft tissue infections (for example, abscesses or impetigo).

Launch Date

1965
Curative
Broxil

Approved Use

It is indicated for the treatment of infections, caused by susceptible microorganisms. In particular streptococcal infections, such as: upper respiratory tract infections (for example, pharyngitis); lower respiratory tract infections (for example, pneumonia); skin and soft tissue infections (for example, abscesses or impetigo).

Launch Date

1965
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
23 μg/mL
500 mg 1 times / day steady-state, oral
dose: 500 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
PHENETICILLIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
29.3 μg × h/mL
500 mg 1 times / day steady-state, oral
dose: 500 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
PHENETICILLIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
63 min
500 mg 1 times / day steady-state, oral
dose: 500 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
PHENETICILLIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
20%
500 mg 1 times / day steady-state, oral
dose: 500 mg
route of administration: Oral
experiment type: STEADY-STATE
co-administered:
PHENETICILLIN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE
food status: FASTED
Doses

Doses

DosePopulationAdverse events​
250 mg 4 times / day multiple, oral
Highest studied dose
Dose: 250 mg, 4 times / day
Route: oral
Route: multiple
Dose: 250 mg, 4 times / day
Sources:
unhealthy, 54 (19–71)
n = 120
Health Status: unhealthy
Condition: Infection
Age Group: 54 (19–71)
Sex: M+F
Population Size: 120
Sources:
1 g 1 times / day single, oral
Highest studied dose
Dose: 1 g, 1 times / day
Route: oral
Route: single
Dose: 1 g, 1 times / day
Sources:
unhealthy, 58.3±15.4(19–90)
n = 84
Health Status: unhealthy
Condition: Infection
Age Group: 58.3±15.4(19–90)
Sex: M+F
Population Size: 84
Sources:
250 mg 3 times / day multiple, oral
Recommended
Dose: 250 mg, 3 times / day
Route: oral
Route: multiple
Dose: 250 mg, 3 times / day
Sources:
unhealthy, adult
n = 437
Health Status: unhealthy
Condition: Infection
Age Group: adult
Sex: M+F
Population Size: 437
Sources:
Disc. AE: Dermatitis, Throbbing headache...
AEs leading to
discontinuation/dose reduction:
Dermatitis
Throbbing headache
Hypersensitivity reaction
Sources:
AEs

AEs

AESignificanceDosePopulation
Dermatitis Disc. AE
250 mg 3 times / day multiple, oral
Recommended
Dose: 250 mg, 3 times / day
Route: oral
Route: multiple
Dose: 250 mg, 3 times / day
Sources:
unhealthy, adult
n = 437
Health Status: unhealthy
Condition: Infection
Age Group: adult
Sex: M+F
Population Size: 437
Sources:
Hypersensitivity reaction Disc. AE
250 mg 3 times / day multiple, oral
Recommended
Dose: 250 mg, 3 times / day
Route: oral
Route: multiple
Dose: 250 mg, 3 times / day
Sources:
unhealthy, adult
n = 437
Health Status: unhealthy
Condition: Infection
Age Group: adult
Sex: M+F
Population Size: 437
Sources:
Throbbing headache Disc. AE
250 mg 3 times / day multiple, oral
Recommended
Dose: 250 mg, 3 times / day
Route: oral
Route: multiple
Dose: 250 mg, 3 times / day
Sources:
unhealthy, adult
n = 437
Health Status: unhealthy
Condition: Infection
Age Group: adult
Sex: M+F
Population Size: 437
Sources:
PubMed

PubMed

TitleDatePubMed
Identification of penicillin allergenic determinants that bind IgE antibodies in the sera of subjects with penicillin allergy.
1990 Nov
A prospective placebo-controlled double-blind trial of antibiotic prophylaxis in intraoral bone grafting procedures: a pilot study.
2003 Dec
The history of penicillin from discovery to the drive to production.
2004 Sep
Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
2008 Feb
A complete library of amino acid alterations at R306 in Streptomyces clavuligerus deacetoxycephalosporin C synthase demonstrates its structural role in the ring-expansion activity.
2008 Feb 15
Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.
2010 Jan 20
Patents

Patents

Sample Use Guides

250 mg every 8 hours
Route of Administration: Oral
In Vitro Use Guide
The MIC against S. aureus of Pheneticillin in broth was 0.031 mg/l.
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:19:57 GMT 2023
Edited
by admin
on Fri Dec 15 18:19:57 GMT 2023
Record UNII
EFA30X554H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHENETICILLIN
INN   WHO-DD  
INN  
Official Name English
.ALPHA.-PHENOXYETHYLPENICILLIN
Common Name English
pheneticillin [INN]
Common Name English
NSC-117548
Code English
Pheneticillin [WHO-DD]
Common Name English
ALFACILIN
Brand Name English
FENETICILLIN
Common Name English
SYNTHEPEN
Brand Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 3,3-DIMETHYL-7-OXO-6-((1-OXO-2-PHENOXYPROPYL)AMINO)-, (2S,5R,6R)-
Common Name English
(2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-(2-PHENOXYPROPIONAMIDO)-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE
Systematic Name English
PHENETHICILLIN
Common Name English
Classification Tree Code System Code
WHO-ATC J01CE05
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
WHO-VATC QJ01CE05
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
Code System Code Type Description
CAS
147-55-7
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
SMS_ID
100000082232
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
CHEBI
52427
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
WIKIPEDIA
PHENETICILLIN
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
DRUG CENTRAL
2124
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
PUBCHEM
272833
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
FDA UNII
EFA30X554H
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
DRUG BANK
DB13337
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
EVMPD
SUB09759MIG
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
NCI_THESAURUS
C170316
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
NSC
117548
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
ChEMBL
CHEMBL1614637
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
RXCUI
33277
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY RxNorm
ECHA (EC/EINECS)
205-691-4
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
INN
1011
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID6023448
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
MESH
C100209
Created by admin on Fri Dec 15 18:19:58 GMT 2023 , Edited by admin on Fri Dec 15 18:19:58 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY